Personalized Treatment for Endometriosis: A Study on the Safety and Kinetics of Dienogest in Women with Different Gene Variants

2025-521026-15-00 Protocol PriMEPGx-CYP3A4-Dien Human pharmacology (Phase I) - Other Authorised, recruiting

Start 11 Dec 2025 · Status Authorised, recruiting · 1 EU/EEA countries · 1 sites · Protocol PriMEPGx-CYP3A4-Dien

Overview

Sponsor-declared trial summary

Phase Human pharmacology (Phase I) - Other
Status Authorised, recruiting
Participants planned 48
Countries 1
Sites 1

Healthy volunteers

Key facts

Sponsor
Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Princesa
Participant type
Healthy volunteers
Age range
18-64 years
Gender
Female
Therapeutic area
Phenomena and Processes [G] - Metabolism [G03], Phenomena and Processes [G] - Reproductive and Urinary Physiological Phenomena [G08]
Trial duration
11 Dec 2025 → ongoing
Decision date (initial)
2025-03-18
Transition trial
No
Low-intervention
No
Rare-disease indication
No
Vulnerable population
No

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

Healthy volunteers

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Princesa

6 Total trials 5 Recruiting
Academic / Non-commercial
Sponsor organisation
Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Princesa
Address
Calle De Diego De Leon 62
City
Madrid
Postcode
28006
Country
Spain

Scientific contact point

Organisation
Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Princesa
Contact name
Gina Paola Mejía Abril

Public contact point

Organisation
Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Princesa
Contact name
Gina Paola Mejía Abril

Locations

1 EU/EEA country · 1 investigational sites

By country

CountryMS statusPlanned subjectsSites
Spain Authorised, recruiting 48 1
Rest of world 0

Investigational sites

Spain

1 site · Authorised, recruiting
Hospital Universitario De La Princesa
Clinical Pharmacology, Calle De Diego De Leon 62, 28006, Madrid

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country Trial startTrial end Recruitment startRecruitment end Early termination
Spain 2025-12-11

Application history

2 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2025-02-06 Spain Acceptable
2025-03-18
2025-03-18
2 SUBSTANTIAL MODIFICATION SM-2 2026-01-15 Spain Acceptable
2026-03-23
2026-03-30